<DOC>
	<DOCNO>NCT02265653</DOCNO>
	<brief_summary>The objective present study investigate relative bioavailability two BIIL 284 BS tablet ( tablet C tablet C ) comparison WIF tablet dose 75 mg follow standard breakfast healthy male volunteer</brief_summary>
	<brief_title>Relative Bioavailability , Pharmacokinetics , Safety Tolerability BIIL 284 BS Healthy Volunteers</brief_title>
	<detailed_description />
	<criteria>All participant healthy male Age range 21 50 year BrocaIndex : within + 20 % normal weight In accordance Good Clinical Practice ( GCP ) local legislation volunteer suppose give write informed consent prior admission study Volunteers exclude study result medical examination laboratory test judge clinical investigator differ significantly normal clinical value Volunteers know gastrointestinal , hepatic , renal , respiratory , cardiovascular , metabolic , immunological hormonal disorder Volunteers diseases central nervous system ( epilepsy ) psychiatric disorder Volunteers history orthostatic hypotension , faint spell blackouts Volunteers chronic relevant acute infection Volunteers history allergy/hypersensitivity ( include drug allergy ) deem relevant trial judge investigator Volunteers take drug long halflife ( &gt; = 24 hour ) within one month less ten halflives respective drug enrollment study Volunteers receive drug might influence result trial week previous start study Volunteers participate another study investigational drug within last two month precede study Volunteers smoke ( &gt; 10 cigarette 3 cigar 3 pipes/day ) Volunteers drink 60g alcohol per day Volunteers dependent drug Volunteers participate excessive physical activity ( e.g . competitive sport ) within last week study Volunteers donate blood within last 4 week ( &gt; = 100 mL )</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>October 2014</verification_date>
</DOC>